Skip to main content
Publications
Hogue SL, Bennett ME, Goss DS, Hollis KA, Millar K, Silvia S, Siegel P, Wolf R, Wooddell M, White MV. Availability and use of epinephrine auto-injectors for the treatment of anaphylaxis: results from the EpiPen4Schools® survey. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A178. doi: 10.1016/j.jval.2015.03.1030
Mladsi DM, Goyal RK, Cryer B, Hopkins WE, Brater CD, Korsnes JS, Candrilli SD, Castellsague J, Varas-Lorenzo C. Risk of cardiovascular, gastrointestinal, and renal adverse events associated with diclofenac immediate and extended release drug products: an observational study using US claims data. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A292.
Mahida SR, Seoane E, Klinger E, Salazar A, HER QL, Medoff J, Amato M, Dykes PC, Haas J, Bates D, Schiff G. Cost of reporting possible adverse drug reactions in medical outpatients using a telephonic interactive voice response system. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 20, 2015. Philadelphia, PA. [abstract] Value Health. 2015 May 1; 18(3):PA257. doi: 10.1016/j.jval.2015.03.1498
Doward L, Højbjerre L, Hogue S, Fernandez M, Barrett A, Crawford R, Kragh N, Aagren M. Influence of patient-reported outcomes on regulatory, HTA, and market access decisions: obesity and diabetes case examples. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015; 18:A1-A333.